Johnson is not starting his anti-death quest from optimal circumstances
Trials like EMPAREG OUTCOME and REWIND underscore how newer medications reshape risk management, leading some experts to recommend earlier initiation of these agents in patients with elevated cardiovascular or renal risks
J Eur Acad Dermatol Venereol 1999;13:205-9
However, the associations between GLP-1RAs and bulimia nervosa or PTSD were based solely on evidence from Mendelian randomization analysis
Key facts about GLP-1-related gastroparesis: How it happens: GLP-1 drugs slow gastric emptying as part of their mechanism, but this effect becomes excessive in some people Whos at risk: Those with pre-existing digestive disorders, prior gastric surgery, long-standing diabetes, or elderly patients face higher risk Timeline: Symptoms can appear at any point during treatment, especially during dose increases Reversibility: Most cases improve after dose reduction or medication discontinuation, with recovery taking days to several months Management options: Dietary changes (smaller, low-fat meals), slower dose escalation, supportive medications, or temporary drug cessation Seek immediate medical attention for severe vomiting, dehydration signs, intense abdominal pain, or blood in vomit or stool
Expanded Access: Oral medications may appeal to individuals who would otherwise avoid treatment
.jpg)
